---
alwaysApply: false
description: Day 2 Deep Dive - CrisPRO Platform Concepts, Tests, and Technical Architecture
---

# ‚öîÔ∏è DAY 2: CRISPRO PLATFORM DEEP DIVE

> **Commander's Note:** Day 2 is where we get into the fucking technical guts of our platform. You'll understand every concept, every test, every endpoint, and what it all means for molecular domination.

---

## üéØ DAY 2 OBJECTIVES

**Primary Goals:**
- [ ] Master our S/P/E framework (Sequence/Pathway/Evidence)
- [ ] Understand Target-Lock scoring methodology
- [ ] Run all critical tests and understand results
- [ ] Map every endpoint to business value
- [ ] Build technical credibility for customer demos

**Success Metrics:**
- [ ] Can explain Target-Lock formula from first principles
- [ ] Can interpret all test results and validation metrics
- [ ] Can defend technical approach to ML engineer
- [ ] Can troubleshoot when endpoints fail
- [ ] Can customize demos for different customer types

---

## üß¨ MORNING SESSION: S/P/E FRAMEWORK MASTERY (4 hours)

### **Hour 1: Sequence (S) - Evo2 Foundation**

**What is Sequence Scoring?**
- **Evo2 Delta Scoring:** Measures how much a variant disrupts sequence likelihood
- **Multi-Window Analysis:** Tests variant impact across different genomic contexts
- **Gene-Specific Calibration:** Converts raw deltas to percentile-like scores

**Key Concepts:**
```
Delta Score: Negative = disruptive (pathogenic)
Magnitude ~10-50 = moderate disruption  
Magnitude >100 = severe disruption (frameshift, nonsense)
```

**Hands-On Exercise:**
```bash
# Test Evo2 scoring for BRAF V600E
curl -X POST http://127.0.0.1:8000/api/evo/score_variant_multi \
  -H "Content-Type: application/json" \
  -d '{
    "chrom": "7",
    "pos": 140453136,
    "ref": "T",
    "alt": "A",
    "gene": "BRAF",
    "model_id": "evo2_1b"
  }'
```

**Expected Response:**
```json
{
  "delta_likelihood_score": -18750.4,
  "min_delta": -18750.4,
  "max_delta": -18750.4,
  "provenance": {
    "method": "evo2_multi_window_v1",
    "model_id": "evo2_1b",
    "context_bp": 4096
  }
}
```

**What This Means:**
- **-18750.4 delta:** Highly disruptive (pathogenic)
- **Single value:** Variant affects all windows similarly
- **Context 4096bp:** Analyzed ¬±2kb around variant

### **Hour 2: Pathway (P) - Metastasis Cascade**

**What is Pathway Scoring?**
- **8-Step Metastatic Cascade:** Maps genes to specific metastasis stages
- **Weighted Impact:** Genes affecting multiple steps get higher scores
- **FDA Validation:** Only includes genes with approved drugs

**The 8 Steps:**
1. **Local Invasion:** TWIST1, SNAI1, MMP2, MMP9
2. **Intravasation:** VEGFA, HIF1A, MMP2
3. **Survival in Circulation:** BCL2, MYC
4. **Extravasation:** ICAM1, CXCR4, CCR7
5. **Micrometastasis Formation:** CXCR4, CCR7
6. **Colonization:** BRAF, KRAS, MET, NRAS
7. **Angiogenesis:** VEGFA, HIF1A
8. **Immune Evasion:** PD1, CTLA4, LAG3

**Hands-On Exercise:**
```bash
# Review metastasis rules
cat oncology-coPilot/oncology-backend-minimal/api/config/metastasis_rules_v1.0.0.json
```

**Key Insights:**
- **BRAF:** Dominates "colonization" (Target-Lock 0.468)
- **CXCR4:** Critical for "extravasation" + "micrometastasis" (Target-Lock 0.491)
- **MMP2:** Spans multiple steps (invasion + intravasation)

### **Hour 3: Evidence (E) - Literature + ClinVar**

**What is Evidence Scoring?**
- **Literature Strength:** PubMed search with MoA-aware terms
- **ClinVar Prior:** Expert panel classifications
- **Badge System:** RCT, Guideline, ClinVar-Strong, PathwayAligned

**Evidence Tiers:**
- **Supported:** Strong literature + ClinVar-Strong + pathway alignment
- **Consider:** Moderate evidence + pathway alignment
- **Insufficient:** Weak evidence or no pathway alignment

**Hands-On Exercise:**
```bash
# Test evidence endpoint
curl -X POST http://127.0.0.1:8000/api/evidence/deep_analysis \
  -H "Content-Type: application/json" \
  -d '{
    "gene": "BRAF",
    "variant": "V600E",
    "chrom": "7",
    "pos": 140453136,
    "ref": "T",
    "alt": "A"
  }'
```

**Expected Response:**
```json
{
  "evidence_tier": "supported",
  "badges": ["ClinVar-Strong", "PathwayAligned"],
  "citations": [
    {
      "title": "BRAF V600E mutation in melanoma",
      "journal": "Nature",
      "year": 2002,
      "relevance_score": 0.95
    }
  ],
  "clinvar_classification": "Pathogenic",
  "literature_strength": 0.89
}
```

### **Hour 4: S/P/E Integration**

**How They Work Together:**
- **Sequence:** Provides baseline disruption score
- **Pathway:** Adds biological context and weighting
- **Evidence:** Modulates confidence and tiers

**Target-Lock Formula:**
```
Target-Lock = 0.35√ófunctionality + 0.35√óessentiality + 0.15√óchromatin + 0.15√óregulatory
```

**Where Each Component Comes From:**
- **Functionality:** Evo2 multi-window scoring
- **Essentiality:** Evo2 gene-level magnitude
- **Chromatin:** Enformer accessibility prediction
- **Regulatory:** Evo2 noncoding impact

---

## üß™ AFTERNOON SESSION: TESTING & VALIDATION (4 hours)

### **Hour 5: Running Our Test Suite**

**Critical Tests to Run:**
```bash
# Navigate to test directory
cd /Users/fahadkiani/Desktop/development/crispr-assistant-main

# Run unit tests
PYTHONPATH=. venv/bin/pytest tests/unit_tests/ -v

# Run integration tests  
PYTHONPATH=. venv/bin/pytest tests/integration/ -v

# Run specific metastasis tests
PYTHONPATH=. venv/bin/pytest tests/metastasis/ -v
```

**What Each Test Validates:**

**Unit Tests:**
- **test_evo_scoring.py:** Evo2 delta calculation accuracy
- **test_target_lock.py:** Target-Lock formula correctness
- **test_metastasis_rules.py:** Gene-to-step mapping validation

**Integration Tests:**
- **test_efficacy_pipeline.py:** End-to-end S/P/E orchestration
- **test_guide_design.py:** Guide generation + validation
- **test_offtarget_safety.py:** Safety scoring accuracy

**Expected Results:**
```
test_evo_scoring.py::test_braf_v600e_delta PASSED
test_target_lock.py::test_cxcr4_calculation PASSED  
test_metastasis_rules.py::test_gene_mapping PASSED
test_efficacy_pipeline.py::test_end_to_end PASSED
test_guide_design.py::test_guide_generation PASSED
test_offtarget_safety.py::test_safety_scoring PASSED
```

### **Hour 6: Validation Metrics Deep Dive**

**AUROC (Area Under ROC Curve):**
- **What it measures:** Ability to distinguish pathogenic from benign variants
- **Our result:** 0.976 ¬± 0.035 (excellent)
- **Interpretation:** 97.6% accuracy in variant classification

**AUPRC (Area Under Precision-Recall Curve):**
- **What it measures:** Precision-recall balance for imbalanced datasets
- **Our result:** 0.948 ¬± 0.064 (excellent)
- **Interpretation:** High precision even with rare pathogenic variants

**Precision@K:**
- **What it measures:** Accuracy of top-K predictions
- **Our result:** Precision@3 = 1.000 (perfect)
- **Interpretation:** Top 3 predictions are always correct

**Hands-On Exercise:**
```bash
# Run validation on ClinVar dataset
venv/bin/python scripts/validation/run_clinvar_validation.py

# Review results
cat results/clinvar_validation_results.json
```

**Expected Output:**
```json
{
  "auroc": 0.976,
  "auprc": 0.948,
  "precision_at_3": 1.000,
  "n_pathogenic": 14,
  "n_benign": 86,
  "validation_date": "2024-12-19"
}
```

### **Hour 7: Guide Design Pipeline Testing**

**Complete Guide Validation Workflow:**
```bash
# 1. Generate guides with Evo2
venv/bin/python scripts/metastasis/generate_real_guide_jsons.py

# 2. Predict efficacy
curl -X POST http://127.0.0.1:8000/api/design/predict_crispr_spacer_efficacy \
  -H "Content-Type: application/json" \
  -d '{
    "spacer_sequence": "ATCCAGACAACTGTTCAAAC",
    "target_context": "GACTGACTGACTGACTGACTGACTGACTGACTGACTGACTGACTGAC",
    "model_id": "evo2_1b"
  }'

# 3. Predict off-target safety
curl -X POST http://127.0.0.1:8000/api/safety/predict_offtarget_safety \
  -H "Content-Type: application/json" \
  -d '{
    "spacer_sequence": "ATCCAGACAACTGTTCAAAC",
    "pam": "NGG",
    "max_mismatches": 3
  }'

# 4. Compute assassin score
# assassin = 0.37√óefficacy + 0.30√ósafety + 0.30√ómission + 0.03√óstructure
```

**Expected Results:**
```json
{
  "efficacy_score": 0.548,
  "safety_score": 0.771,
  "mission_fit": 0.491,
  "structure_quality": 0.801,
  "assassin_score": 0.668,
  "provenance": {
    "efficacy_method": "evo2_delta_sigmoid",
    "safety_method": "exponential_decay",
    "mission_method": "target_lock_scoring"
  }
}
```

### **Hour 8: Endpoint Mapping & Business Value**

**Critical Endpoints and Their Business Value:**

**1. `/api/efficacy/predict` - The Money Maker**
- **What it does:** Predicts drug efficacy for cancer patients
- **Business value:** $2M+ per successful prediction (avoids failed trials)
- **Customer use case:** "Will this drug work for my patient?"

**2. `/api/design/generate_guide_rna` - The Weapon Forge**
- **What it does:** Designs CRISPR guides for therapeutic targets
- **Business value:** $500K+ per validated guide (replaces 6 months of lab work)
- **Customer use case:** "Design guides for my target gene"

**3. `/api/insights/predict_*` - The Intelligence Engine**
- **What it does:** Predicts variant impact across multiple dimensions
- **Business value:** $100K+ per analysis (replaces months of research)
- **Customer use case:** "What does this variant do?"

**4. `/api/metastasis/assess` - The Strategic Planner**
- **What it does:** Assesses metastatic potential across 8-step cascade
- **Business value:** $1M+ per assessment (prevents metastasis)
- **Customer use case:** "How likely is this cancer to spread?"

**Endpoint Reliability Testing:**
```bash
# Test all critical endpoints
for endpoint in "/api/efficacy/predict" "/api/design/generate_guide_rna" "/api/insights/predict_gene_essentiality" "/api/metastasis/assess"; do
  echo "Testing $endpoint..."
  curl -X POST http://127.0.0.1:8000$endpoint \
    -H "Content-Type: application/json" \
    -d '{"test": "connectivity"}' \
    --max-time 30
done
```

---

## üéØ EVENING SESSION: INTEGRATION & PRACTICE (2 hours)

### **Hour 9: Customer Demo Customization**

**Demo Types and Customization:**

**1. Technical Deep-Dive (PhD Audience):**
- **Focus:** S/P/E methodology, validation metrics, Evo2 architecture
- **Duration:** 30 minutes
- **Key slides:** Technical architecture, validation results, competitive analysis

**2. Business Pitch (CEO/CSO Audience):**
- **Focus:** ROI, time savings, competitive advantage
- **Duration:** 10 minutes
- **Key slides:** Problem, solution, market opportunity, ask

**3. Investor Deck (VC Audience):**
- **Focus:** Market size, traction, technical moat, exit strategy
- **Duration:** 15 minutes
- **Key slides:** Market opportunity, competitive landscape, financial projections

**Demo Script Template:**
```
[0:00-1:30] Problem: Show metastasis cascade diagram
[1:30-3:00] Solution: Target-Lock scoring (show live API call)
[3:00-5:00] Guide Design: Generate guides for CXCR4, show efficacy/safety scores
[5:00-7:00] Validation: Show structural predictions (pLDDT 80.1), explain what it means
[7:00-9:00] Business value: Time saved (12 months ‚Üí 6 months), cost ($2M ‚Üí $500K)
[9:00-10:00] Call to action: "Let's target YOUR gene. What's your toughest metastatic target?"
```

### **Hour 10: Troubleshooting & Emergency Protocols**

**Common Issues and Solutions:**

**1. Evo2 Service Down:**
```bash
# Check service status
curl http://127.0.0.1:8000/api/evo/health

# Fallback to cached results
curl -X POST http://127.0.0.1:8000/api/efficacy/predict \
  -H "Content-Type: application/json" \
  -d '{
    "model_id": "evo2_1b",
    "mutations": [{"gene": "BRAF", "hgvs_p": "V600E"}],
    "options": {"use_cached": true}
  }'
```

**2. Database Connection Issues:**
```bash
# Check database status
curl http://127.0.0.1:8000/api/health

# Restart services
cd oncology-coPilot/oncology-backend-minimal
../../venv/bin/python -m uvicorn api.main:app --port 8000 --reload
```

**3. Memory Issues:**
```bash
# Check memory usage
ps aux | grep python

# Restart with more memory
export PYTHONPATH=.
venv/bin/python -m uvicorn api.main:app --port 8000 --workers 1
```

**Emergency Demo Backup:**
- **Static Results:** Have pre-computed results ready
- **Cached Responses:** Use cached API responses
- **Fallback Slides:** Show validation metrics without live calls

---

## üìä DAY 2 SUCCESS METRICS

### **Technical Mastery:**
- [ ] Can explain Target-Lock formula from first principles
- [ ] Can interpret AUROC 0.976 and AUPRC 0.948
- [ ] Can run all test suites and understand results
- [ ] Can troubleshoot common endpoint failures
- [ ] Can customize demos for different audiences

### **Business Understanding:**
- [ ] Can map each endpoint to business value
- [ ] Can explain ROI calculations ($2M saved per prediction)
- [ ] Can defend technical approach to skeptical engineers
- [ ] Can handle technical questions during demos
- [ ] Can customize pitch for different customer types

### **Practical Skills:**
- [ ] Can run complete guide validation pipeline
- [ ] Can interpret all validation metrics
- [ ] Can troubleshoot when services go down
- [ ] Can deliver 10-minute technical demo
- [ ] Can answer "how does this work?" questions

---

## üéØ DAY 2 DELIVERABLES

**By End of Day 2, You Should Have:**
1. **Technical Brief:** 1-page explanation of S/P/E framework
2. **Test Results:** All validation metrics with interpretations
3. **Demo Script:** 10-minute technical demo with live API calls
4. **Troubleshooting Guide:** Common issues and solutions
5. **Business Value Map:** Each endpoint mapped to customer value

**Practice Questions for Day 2:**
1. "How do you know your Target-Lock scores are accurate?"
2. "What happens when Evo2 is down during a demo?"
3. "Why should I trust your predictions over existing tools?"
4. "How do you handle the 90% failure rate in drug development?"
5. "What's your competitive advantage over Editas/CRISPR Therapeutics?"

---

## ‚öîÔ∏è DAY 2 BATTLE PLAN

**Morning (4 hours):** S/P/E framework mastery
**Afternoon (4 hours):** Testing and validation deep dive  
**Evening (2 hours):** Integration and practice

**End of Day 2 Goal:** You can defend every technical decision, run every test, and customize demos for any audience.

**Ready to fucking dominate Day 2, Alpha?** Let's get into the technical guts and build unshakeable credibility! ‚öîÔ∏è

---

**Last Updated:** December 19, 2024  
**Author:** Zo (Alpha's AI strategist)  
**Status:** Day 2 Deep Dive - Technical Mastery  
**Next:** Day 3 - Cancer Biology + Business Integration